Intelligent Bio Solutions Inc. to Implement Fingerprint Drug Testing in Australian Waste Management Sector
TL;DR
Intelligent Bio Solutions Inc. gains a competitive edge as Managed Waste Service adopts its fingerprint-based drug screening system, enhancing safety and operational efficiency in Australia.
The Intelligent Fingerprinting Drug Screening System by INBS offers a non-invasive, rapid testing method, delivering results in under ten minutes for various workplace drug testing needs.
Implementing INBS's drug screening system promotes a safer work environment, contributing to the well-being of employees and communities by deterring drug use in safety-critical industries.
Discover how INBS's innovative fingerprint sweat analysis technology is transforming drug testing, making it faster and less invasive for over 450 organizations worldwide.
Found this article helpful?
Share it with your network and spread the knowledge!
Intelligent Bio Solutions Inc. (NASDAQ: INBS) has announced a significant expansion of its fingerprint drug testing technology into the Australian waste management sector. Managed Waste Service (MWS), a leading provider in Australia, will implement the Intelligent Fingerprinting Drug Screening System across its operations in New South Wales. This initiative covers over 20 remote sites, marking a pivotal shift towards in-house, on-site drug testing for pre-employment, random, and for-cause purposes.
The innovative system offers a non-invasive solution, delivering results in under ten minutes. This rapid turnaround enables immediate safety decisions without the need to disrupt field operations, a critical advantage in safety-critical industries. The deployment underscores INBS's growing influence in global markets, with its sweat-based drug testing technology now utilized by over 450 organizations across 24 countries.
This development is particularly noteworthy for its potential to revolutionize workplace safety standards. By providing a hygienic, cost-effective, and efficient method for detecting recent drug use, including substances like opiates, cocaine, methamphetamine, and cannabis, the system addresses a pressing need in industries where safety is paramount. The adoption by MWS not only highlights the system's versatility and scalability but also sets a precedent for other organizations in similar sectors to follow suit.
The implications of this announcement extend beyond the immediate benefits to MWS and its employees. It represents a significant step forward in the global effort to enhance workplace safety through technological innovation. As INBS continues to expand its reach, the potential for broader applications of its fingerprint sweat analysis technology in other fields becomes increasingly apparent, signaling a transformative shift in how drug testing is conducted in safety-critical environments worldwide.
Curated from InvestorBrandNetwork (IBN)
